NCT02946229 is a NA clinical trial of Ultrasound scan in Endstage Renal Disease, sponsored by GE Healthcare.

Who is sponsoring NCT02946229?

NCT02946229 is sponsored by GE Healthcare.

What drugs are being tested in NCT02946229?

Interventions in NCT02946229: Ultrasound scan.

What condition does NCT02946229 study?

NCT02946229 studies Endstage Renal Disease.

Is NCT02946229 still recruiting?

NCT02946229 is currently completed. Last updated 2 November 2018.

Are results published for NCT02946229?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2018-11-02 · How we verify

NCT02946229

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Data Collection for Next Generation Ultrasound Technology Development

Completed NA Results posted Last updated 2 November 2018

What this trial tests

NA trial testing Ultrasound scan in Endstage Renal Disease in 142 participants. Completed in 6 December 2016.

Timeline

26 October 2016

Primary endpoint
6 December 2016

6 December 2016

Quick facts

Lead sponsor	GE Healthcare
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	142
Start date	26 October 2016
Primary completion	6 December 2016
Estimated completion	6 December 2016
Sites	1 location across United States

Drugs / interventions tested

Ultrasound scan

Conditions studied

Endstage Renal Disease — all drugs for Endstage Renal Disease →

Sponsor

GE Healthcare — full company profile →

Who can join

18 and older, any sex, with Endstage Renal Disease. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Diagnostic Ultrasound Exams Primary · 1 day

Collection (number) of ultrasound images representative of sonographic findings routinely observed in the general imaging population.

Group	Value	95% CI
MHD Population Ultrasound	142

Sponsor's own description

The study is designed to collect data from a ultrasound device being used to evaluate feasibility of next generation algorithms for ultrasound data processing and does not test any health outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound scan

Trials testing the same drug.

NCT04857476 — Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound? · NA · terminated
NCT04194736 — Evaluation of the Occurrence of Early Thrombosis on Central Venous Catheter by Ultrasound in Pediatric Intensive Care Un · NA · completed
NCT04547270 — High Definition Ultrasound Imaging of the Intermuscular Bridges at the Interscalene Groove · completed
NCT04127149 — Evaluation of Ultra-portable Ultrasound in General Practice · NA · completed
NCT04174235 — Prevalence of Fetal Congenital Anomalies Among Pregnant Women Attending University Hospital · completed

Other GE Healthcare trials

Trials by the same sponsor.

NCT07472491 — A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients · Phase 2, PHASE3 · recruiting
NCT07394140 — NMT EasyFit Sensor and Cable · NA · not yet recruiting
NCT07024472 — NIBP Cuff Comparison Study · completed
NCT06835647 — Maternal Fetal Device Performance Twins · NA · recruiting
NCT06639828 — Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02946229 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GE Healthcare
Last refreshed: 2 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02946229.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing